ArticleInternational journal of clinical oncology2024
Granulocyte colony-stimulating factor has the potential to attenuate the therapeutic efficacy of chemo-immunotherapy for extensive-stage small-cell lung cancer.
Yuki Tsukazaki et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it